Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• Breakthrough Business Models:Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary (2008) (ISBN 0309120888) Theresa Wizeman, Sally Robinson, and Robert Giffin, Forum on Drug Discovery, Development, and Translation, Institute of Medicine


• NIH Extramural Center Programs: Criteria for Initiation and Evaluation (2004) (ISBN 0309091527) Frederick J. Manning, Michael McGeary, Ronald Estabrook, Editors, Committee for Assessment of NIH Centers of Excellence Programs


• Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: Workshop Summary (2012) (ISBN 0309222141) Steve Olson and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Rare Diseases and Orphan Products: Accelerating Research and Development (2011) (ISBN 0309158060) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine


• Building a National Framework for the Establishment of Regulatory Science for Drug Development:Workshop Summary (2011) (ISBN 0309158893) Yeonwoo Lebovitz, Rebecca English, and Anne Claiborne; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Establishing Precompetitive Collaborations to Stimulate Genomics-Driven Drug Development: Workshop Summary (2011) (ISBN 0309161827) Steve Olson and Adam Berger, Rapporteurs; Roundtable on Translating Genomic-Based Research on Health; Institute of Medicine


• The AIDS Research Program of the National Institutes of Health (1991) (ISBN 0309044367) Committee to Study the AIDS Research Program of the National Institutes of Health


• Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary (2012) (ISBN 0309253152) Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine


• Venture Philanthropy Strategies to Support Translational Research:Workshop Summary (2009) (ISBN 030911666X) Sarah Hanson, Lori Nadig, and Bruce Altevogt, Rapporteurs; Forum on Neuroscience and Nervous System Disorders; Institute of Medicine


• Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment (2007) (ISBN 030910386X) Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment, Sharyl J. Nass and Harold L. Moses, Editors


• Addressing the Threat of Drug-Resistant Tuberculosis:A Realistic Assessment of the Challenge: Workshop Summary (2009) (ISBN 0309130441) Robert Giffin and Sally Robinson, Rapporteurs; Institute of Medicine


• Spinal Cord Injury: Progress, Promise, and Priorities (2005) (ISBN 0309095859) Catharyn T. Liverman, Bruce M. Altevogt, Janet E. Joy, and Richard T. Johnson, Editors, Committee on Spinal Cord Injury


• Measuring the Impacts of Federal Investments in Research: A Workshop Summary (2011) (ISBN 0309217482) Steve Olson and Stephen Merrill, Rapporteurs; Committee on Measuring Economic and Other Returns on Federal Research Investments; The National Academies


• Preventing Medication Errors: Quality Chasm Series (2007) (ISBN 0309101476) Committee on Identifying and Preventing Medication Errors, Philip Aspden, Julie Wolcott, J. Lyle Bootman, Linda R. Cronenwett, Editors


• Scientific Opportunities and Public Needs:Improving Priority Setting and Public Input at the National Institutes of Health (1998) (ISBN 030906130X) Committee on the NIH Research Priority-Setting Process, Institute of Medicine